Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 4/20 | 0.60 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.32 |
| ▸ | PLK1 | P53350 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6732332 | 0.90 | CYP2C9 (0.61) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6736663 | 0.89 | MAPK1 (0.64) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6231418 | 0.89 | CYP2C9 (0.62) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6738143 | 0.88 | CYP2C9 (0.74) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6687473 | 0.87 | CYP2C9 (0.77) | CYP2C9NR1I2MAPK1HSD17B10L3MBTL1 | |
| SCHEMBL6741396 | 0.86 | MAPK1 (0.66) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6236665 | 0.85 | CYP2C9 (0.78) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6685206 | 0.84 | CYP2C9 (0.57) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6235865 | 0.84 | CYP2C9 (0.53) | CYP2C9NR1I2MAPK1HSD17B10XBP1 | |
| SCHEMBL6732912 | 0.84 | MAPK1 (0.57) | CYP2C9NR1I2MAPK1HSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004052313-A2 | ANTI-INFECTIVES | SMITHKLINE BEECHAM CORPORATION (US) | 2004-06-24 | — | — | WO | disclosed |